Portuguese researchers have identified antibodies capable of halting the aggregation of the Tau protein, according to HealthNews. The finding, reported by the outlet, points to a possible avenue in Alzheimer's research, where the buildup of Tau is a central area of study.
HealthNews did not include further details in its reporting on the antibodies, the institutions involved, or how the work was carried out.
The same HealthNews report notes a separate project in Lisbon that approaches rare diseases through poetry. A book of poems built from real DNA sequences linked to rare conditions sits at the center of an initiative called rara[mente], whose presentation is announced for Monday, 12 October, in Lisbon.
According to HealthNews, that project aims to bring society closer to the reality of these conditions by bringing together scientific information, literature and human experience.
The two items appeared together in the outlet's coverage, though the antibody research and the Lisbon poetry project are distinct efforts. HealthNews frames the rara[mente] presentation as a way of connecting the public with the lived and scientific dimensions of rare disease.
What to watch next: whether the Portuguese team publishes full data on the Tau antibodies, and how the rara[mente] presentation in Lisbon unfolds.
